Others have been reported to have good potential to be prognostic biomarkers for CRC (CDKN1A, CDKN1B [62,63,64]), stomach cancer (MMP2, [65]) and esophageal cancer (EGFR, PIK3CA, [66,67]). This evidence concerns the gene MMP2 and colorectal carcinoma.